DNMT3L siRNA (Rat)
Référence MBS8205652-15nmol
Conditionnement : 15nmol
Marque : MyBiosource
Contactez votre distributeur local :
Téléphone : +1 850 650 7790
DNMT3L siRNA – DNA (Cytosine-5)-Methyltransferase 3-Like (Rat)
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8205652MBS8205652 is an siRNA targeting DNMT3L. Also known as DNMT3L siRNA (Rat). Reactive in Rat. Host: Synthetic. siRNA to inhibit DNMT3L expression using RNA interference More details
Product Overview
Online Datasheet in PDFProduct Name
DNMT3L, siRNA
Full Product Name
DNMT3L siRNA (Rat)
Product Gene Name
DNMT3L sirna
Product Synonym Names
DNA; cytosine-5)-methyltransferase 3-like
Host
Synthetic
Species Reactivity
Rat
Form/Format
Lyophilized powder
Purity/Purification
> 97%
Specificity
DNMT3L siRNA (Rat) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
Preparation and Storage
Shipped at 4 degree C. Store at -20 degree C for one year.
Molecular Weight
48,279 Da
Negative Control
siRNA Negative Control (Catalog# MBS8241404) is a non-targeting 21 nt siRNA recommended as a negative control for experiments using targeted siRNA transfection.
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use
We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components
We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of rat DNMT3L gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo.
Applications Tested/Suitable for DNMT3L sirna
RNA Interference (RNAi)
Other Notes
Small volumes of DNMT3L sirna vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for DNMT3L. It may not necessarily be applicable to this product.
UniProt Primary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
DNA (cytosine-5)-methyltransferase 3-like
NCBI Official Synonym Full Names
DNA (cytosine-5-)-methyltransferase 3-like
NCBI Official Symbol
Dnmt3l
UniProt Protein Name
DNA (cytosine-5)-methyltransferase 3-like
Protein Family
DNA (cytosine-5)-methyltransferase
UniProt Gene Name
Dnmt3l
UniProt Entry Name
DNM3L_RAT
NCBI Protein Information
DNA (cytosine-5)-methyltransferase 3-like
UniProt Comments for DNMT3L
DNMT3L: Catalytically inactive regulatory factor of DNA methyltransferases. It is essential for the function of DNMT3A and DNMT3B. Activates DNMT3A and DNMT3B by binding to their catalytic domain. Accelerates the binding of DNA and AdoMet to the methyltransferases and dissociates from the complex after DNA binding to the methyltransferases (By similarity)
Protein type: Amino Acid Metabolism - cysteine and methionine; Transcription, coactivator/corepressor
Cellular Component: condensed nuclear chromosome; cytoplasm; cytosol; nuclear heterochromatin; nucleus
Molecular Function: enzyme activator activity; enzyme binding; enzyme regulator activity; metal ion binding
Biological Process: DNA methylation; in utero embryonic development; methylation; negative regulation of transcription, DNA-dependent; placenta development; positive regulation of catalytic activity; regulation of catalytic activity; response to ethanol
Show more Protein type: Amino Acid Metabolism - cysteine and methionine; Transcription, coactivator/corepressor
Cellular Component: condensed nuclear chromosome; cytoplasm; cytosol; nuclear heterochromatin; nucleus
Molecular Function: enzyme activator activity; enzyme binding; enzyme regulator activity; metal ion binding
Biological Process: DNA methylation; in utero embryonic development; methylation; negative regulation of transcription, DNA-dependent; placenta development; positive regulation of catalytic activity; regulation of catalytic activity; response to ethanol
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with DNMT3L sirna
| Reference Product | PubMed Publications |
|---|---|
| Dnmt3a sirna | >120 publications with DNMT3L and Dnmt3a |
| Dnmt3b sirna | >90 publications with DNMT3L and Dnmt3b |
| Dnmt1 sirna | >52 publications with DNMT3L and Dnmt1 |
| Tdg sirna | >2 publications with DNMT3L and Tdg |
Pathways associated with DNMT3L sirna
| Products by Pathway | Pathway Diagram |
|---|---|
| DNA Methylation Pathway antibodies | DNA Methylation Pathway Diagram |
| Epigenetic Regulation Of Gene Expression Pathway antibodies | Epigenetic Regulation Of Gene Expression Pathway Diagram |
| Gene Expression Pathway antibodies | Gene Expression Pathway Diagram |
Diseases associated with DNMT3L sirna
| Disease Name | Pubmed Publications |
|---|---|
| Male Urogenital Diseases Antibodies | >14 publications with DNMT3L and Male Urogenital Diseases |
| Genital Diseases, Male Antibodies | >14 publications with DNMT3L and Genital Diseases, Male |
| Infertility, Male Antibodies | >13 publications with DNMT3L and Infertility, Male |
| Congenital Abnormalities Antibodies | >6 publications with DNMT3L and Congenital Abnormalities |
| Genital Diseases, Female Antibodies | >6 publications with DNMT3L and Genital Diseases, Female |
| Infertility, Female Antibodies | >5 publications with DNMT3L and Infertility, Female |
| Cell Transformation, Neoplastic Antibodies | >4 publications with DNMT3L and Cell Transformation, Neoplastic |
| Oligospermia Antibodies | >3 publications with DNMT3L and Oligospermia |
| Prenatal Exposure Delayed Effects Antibodies | >3 publications with DNMT3L and Prenatal Exposure Delayed Effects |
| Breast Neoplasms Antibodies | >2 publications with DNMT3L and Breast Neoplasms |